100 related articles for article (PubMed ID: 21665181)
41. TP53 codon 72 polymorphism does not affect risk of cervical cancer in patients from The Gambia.
Tanara G; Falugi C; Cesario A; Margaritora S; Russo P; Cosimi A
Int J Biol Markers; 2003; 18(4):280-3. PubMed ID: 14756543
[TBL] [Abstract][Full Text] [Related]
42. Germline mutation in RNASEL predicts increased risk of head and neck, uterine cervix and breast cancer.
Madsen BE; Ramos EM; Boulard M; Duda K; Overgaard J; Nordsmark M; Wiuf C; Hansen LL
PLoS One; 2008 Jun; 3(6):e2492. PubMed ID: 18575592
[TBL] [Abstract][Full Text] [Related]
43. Association of a miR-502-binding site single nucleotide polymorphism in the 3'-untranslated region of SET8 and the TP53 codon 72 polymorphism with cervical cancer in the Chinese population.
Yang SD; Cai YL; Jiang P; Li W; Tang JX
Asian Pac J Cancer Prev; 2014; 15(16):6505-10. PubMed ID: 25169478
[TBL] [Abstract][Full Text] [Related]
44. Elevated serum expression of p53 and association of TP53 codon 72 polymorphisms with risk of cervical cancer in Bangladeshi women.
Mostaid MS; Mumu SB; Haque MA; Sharmin S; Jamiruddin MR; Sayedur Rahman GM; Reza HM
PLoS One; 2021; 16(12):e0261984. PubMed ID: 34962972
[TBL] [Abstract][Full Text] [Related]
45. RNASEL Arg462Gln polymorphism and prostate cancer in PLCO.
Daugherty SE; Hayes RB; Yeager M; Andriole GL; Chatterjee N; Huang WY; Isaacs WB; Platz EA
Prostate; 2007 Jun; 67(8):849-54. PubMed ID: 17407163
[TBL] [Abstract][Full Text] [Related]
46. Interaction between TP53 and XRCC1 increases susceptibility to cervical cancer development: a case control study.
Liu GC; Zhou YF; Su XC; Zhang J
BMC Cancer; 2019 Jan; 19(1):24. PubMed ID: 30616520
[TBL] [Abstract][Full Text] [Related]
47. CASP7 variants modify susceptibility to cervical cancer in Chinese women.
Shi TY; He J; Wang MY; Zhu ML; Yu KD; Shao ZM; Sun MH; Wu X; Cheng X; Wei Q
Sci Rep; 2015 Mar; 5():9225. PubMed ID: 25784056
[TBL] [Abstract][Full Text] [Related]
48. Association of DRD4 uVNTR and TP53 codon 72 polymorphisms with schizophrenia: a case-control study.
Lung FW; Shu BC; Kao WT; Chen CN; Ku YC; Tzeng DS
BMC Med Genet; 2009 Dec; 10():147. PubMed ID: 20040103
[TBL] [Abstract][Full Text] [Related]
49. Lack of influence of TP53 Arg72Pro and 16bp duplication polymorphisms on risk of breast cancer in Iran.
Gohari-Lasaki S; Gharesouran J; Ghojazadeh M; Montazeri V; Mohaddes Ardebili SM
Asian Pac J Cancer Prev; 2015; 16(7):2971-4. PubMed ID: 25854391
[TBL] [Abstract][Full Text] [Related]
50. p53 Codon 72 polymorphism is associated with occurrence of cervical carcinoma in the Chinese population.
Ye F; Zhang J; Cheng Q; Shen J; Chen H
Cancer Lett; 2010 Jan; 287(1):117-21. PubMed ID: 19576684
[TBL] [Abstract][Full Text] [Related]
51. TP53 codon 72 polymorphism and cervical cancer: a pooled analysis of individual data from 49 studies.
Klug SJ; Ressing M; Koenig J; Abba MC; Agorastos T; Brenna SM; Ciotti M; Das BR; Del Mistro A; Dybikowska A; Giuliano AR; Gudleviciene Z; Gyllensten U; Haws AL; Helland A; Herrington CS; Hildesheim A; Humbey O; Jee SH; Kim JW; Madeleine MM; Menczer J; Ngan HY; Nishikawa A; Niwa Y; Pegoraro R; Pillai MR; Ranzani G; Rezza G; Rosenthal AN; Roychoudhury S; Saranath D; Schmitt VM; Sengupta S; Settheetham-Ishida W; Shirasawa H; Snijders PJ; Stoler MH; Suárez-Rincón AE; Szarka K; Tachezy R; Ueda M; van der Zee AG; von Knebel Doeberitz M; Wu MT; Yamashita T; Zehbe I; Blettner M
Lancet Oncol; 2009 Aug; 10(8):772-84. PubMed ID: 19625214
[TBL] [Abstract][Full Text] [Related]
52. Prognostic value of TP53 Pro47Ser and Arg72Pro single nucleotide polymorphisms and the susceptibility to gliomas in individuals from Southeast Brazil.
Pinto GR; Yoshioka FK; Silva RL; Clara CA; Santos MJ; Almeida JR; Burbano RR; Rey JA; Casartelli C
Genet Mol Res; 2008 Feb; 7(1):207-16. PubMed ID: 18393224
[TBL] [Abstract][Full Text] [Related]
53. High twinning rate in Cândido Godói: a new role for p53 in human fertility.
Tagliani-Ribeiro A; Paskulin DD; Oliveira M; Zagonel-Oliveira M; Longo D; Ramallo V; Ashton-Prolla P; Saraiva-Pereira ML; Fagundes NJ; Schuler-Faccini L; Matte U
Hum Reprod; 2012 Sep; 27(9):2866-71. PubMed ID: 22736329
[TBL] [Abstract][Full Text] [Related]
54. Combined Genotype Effects of TP53 and PAI-1 Polymorphisms in Breast Cancer Susceptibility: Multifactor Dimensionality Reduction and in silico Analysis.
Pouladi N; Shavali M; Abdolahi S
Hum Hered; 2020; 85(2):51-60. PubMed ID: 33735891
[TBL] [Abstract][Full Text] [Related]
55. Genetic polymorphisms of TP53 Arg72Pro and Pro47Ser among Egyptian patients with colorectal carcinoma.
Elsaid A; Zahran R; Elshazli R; El-Sayed A; Abou Samra M; El-Tarapely F; Abdel-Malak C
Arch Physiol Biochem; 2019 Jul; 125(3):255-262. PubMed ID: 29560751
[TBL] [Abstract][Full Text] [Related]
56. RNASEL germline variants are associated with pancreatic cancer.
Bartsch DK; Fendrich V; Slater EP; Sina-Frey M; Rieder H; Greenhalf W; Chaloupka B; Hahn SA; Neoptolemos JP; Kress R
Int J Cancer; 2005 Dec; 117(5):718-22. PubMed ID: 15981205
[TBL] [Abstract][Full Text] [Related]
57. RNASEL and RNASEL-inhibitor variation and prostate cancer risk in Afro-Caribbeans.
Shea PR; Ishwad CS; Bunker CH; Patrick AL; Kuller LH; Ferrell RE
Prostate; 2008 Mar; 68(4):354-9. PubMed ID: 18189233
[TBL] [Abstract][Full Text] [Related]
58. [Analysis of associations of polymorphic loci of a tumor suppressor gene TP53 with malignant neoplasms in glass fiber manufacturing workers].
Mukhammadiyeva GF; Bakirov AB; Karimova LK; Valeyeva ET
Gig Sanit; 2014; (4):59-61. PubMed ID: 25842498
[TBL] [Abstract][Full Text] [Related]
59. Arg72Pro TP53 polymorphism and cancer susceptibility: a comprehensive meta-analysis of 302 case-control studies.
Francisco G; Menezes PR; Eluf-Neto J; Chammas R
Int J Cancer; 2011 Aug; 129(4):920-30. PubMed ID: 20886596
[TBL] [Abstract][Full Text] [Related]
60. Role of genetic polymorphisms of the RNASEL gene on familial prostate cancer risk in a Japanese population.
Nakazato H; Suzuki K; Matsui H; Ohtake N; Nakata S; Yamanaka H
Br J Cancer; 2003 Aug; 89(4):691-6. PubMed ID: 12915880
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
